Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.
about
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malariaPractices and impact of primary outcome adjustment in randomized controlled trials: meta-epidemiologic studyMedicinal Plants Qua Glucagon-Like Peptide-1 Secretagogue via Intestinal Nutrient SensorsAntimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR NetworkHow patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugsGlobal analysis of Plasmodium falciparum Na(+)/H(+) exchanger (pfnhe-1) allele polymorphism and its usefulness as a marker of in vitro resistance to quininePlasmodium falciparum Na+/H+ Exchanger (pfnhe-1) Genetic Polymorphism in Indian Ocean Malaria-Endemic AreasHigh adherence to antimalarials and antibiotics under integrated community case management of illness in children less than five years in eastern UgandaAdherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidenceMalaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts.Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmissionArtemether-lumefantrine: an option for malaria.Malaria: an update on current chemotherapy.Treating severe malaria in pregnancy: a review of the evidenceLimited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in UgandaDetection of persistent Plasmodium spp. infections in Ugandan children after artemether-lumefantrine treatment.Drug-Resistant Malaria: The Era of ACT.Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective studySimilar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.Treating uncomplicated malaria in children: comparing artemisinin-based combination therapies.Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study.Chemotherapeutics challenges in developing effective treatments for the endemic malariasIncreased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysis.Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania.Surveillance for the safety and effectiveness of artemether-lumefantrine in patients with uncomplicated Plasmodium falciparum malaria in the USA: a descriptive analysisBudget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania.Anti-malarial prescription practices among outpatients with laboratory-confirmed malaria in the setting of a health facility-based sentinel site surveillance system in Uganda.Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.Impact of retreatment with an artemisinin-based combination on malaria incidence and its potential selection of resistant strains: study protocol for a randomized controlled clinical trialIntervention to promote patients' adherence to antimalarial medication: a systematic review.Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria.Adherence to Artemisinin-Based Combination Therapy for the Treatment of Uncomplicated Malaria: A Systematic Review and Meta-AnalysisThe Relative Effects of Artemether-lumefantrine and Non-artemisinin Antimalarials on Gametocyte Carriage and Transmission of Plasmodium falciparum: A Systematic Review and Meta-analysis.Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysisCoartem(®): a decade of patient-centric malaria management.[A randomized clinical trial comparing the effectiveness and tolerability of artemisinine-naphthoquine (Arco®) and artemether-lumefantrine (Coartem®) in the treatment of uncomplicated malaria in Benin].In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya
P2860
Q17485067-E2EFCA4D-226E-4046-9094-67B9E6465743Q24289045-FB7FF10D-4220-4489-A897-159F0E8827E6Q26770832-9ADCE0A2-DE08-4C96-8C5D-B182877B4F10Q26799713-60E403C5-B86A-4C53-8775-5A09BB405C0BQ26823483-AB9F0AF6-23D2-429A-BBAB-43D0E795C48AQ27012884-F917F658-3485-41B0-9ADC-33D94923D794Q27861961-77211A6F-FA01-4CA7-A57E-E23DD191E142Q28489120-393B82B6-2E42-45EE-A623-EF3F48BFDA9AQ28538749-01C185F0-EA72-434B-AD21-55BFD508C11FQ30226671-3623776A-7591-4909-B15D-F3B69626FAB8Q33635019-60319A01-E0A7-4629-81C3-819E677DB4ACQ33676088-4E3D9478-406A-4F7E-A2F8-4762A765C80FQ34020818-00007A9F-D559-4CE0-BA2D-BA77DA77CBDEQ34267667-CBE0229C-C706-40AB-8F30-37AA7550DE41Q34433106-F3329F1A-A670-40DB-B3AE-C371C38E79C6Q34456393-50F7D33F-90F7-4D34-BBD3-1EF7F27603ECQ34529355-2BBF1C2D-BD80-47F3-9287-0042F7889B7BQ34629332-02001746-8851-4E53-80E0-97827E932297Q34681141-1EE4B299-E3BB-4797-A937-87C4203AECC7Q34728230-5CB28890-C4C2-441B-9977-2AADF875E5E5Q34910448-700AE8FD-3CBD-4EE1-B427-4E7EB147823EQ35004430-C2A78533-1321-4140-8C0C-F1BD7B3AF41EQ35030048-51D50FAE-47B2-4294-B5CB-1F0870269639Q35095657-0CE8AA10-9322-4804-A9C5-C674C5AF459DQ35530639-F3CFBFE2-A228-4B02-A9B8-7FB1B00183B9Q35759007-2CE72DFF-106D-4CBE-A0A8-7C23C7D902FEQ35833995-FDA0FBDA-BD78-44C2-AC9D-6462BB016386Q36069930-60F3DD85-A301-4A28-8D60-E1A22032B590Q36615103-784AE343-E954-4DD8-887C-2D6563F16FF1Q37045375-13CD8836-0A5E-4B54-B9F9-18EEF39E98E4Q37263818-DB7E8716-DE54-44FD-A9F5-2A92E03D68C9Q37361298-ECA1D8AC-7672-42AE-9630-332A62EE6A1BQ37456044-207154BE-F62D-4986-8EAA-5C33FDB6DC55Q37857327-0C2C7957-50CE-4AD0-9582-FB341B5F9745Q38544762-3280B82B-53D8-4CDC-B420-1B18ACAD4D3AQ38840716-3B9A35C0-68D6-42A9-9CFB-954E52F27049Q38895510-9DD32033-819F-4EF0-B7F3-FB715B24EFE3Q39042892-A2907E5D-3F76-4AD9-B031-9E93F8CAFD64Q40296599-D7ADED14-E0F0-41BC-9EFE-78D2BE28254BQ41935745-76869478-2B81-45F1-B067-72FC8CC26F2F
P2860
Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effectiveness of quinine versu ...... an children: randomised trial.
@en
Effectiveness of quinine versu ...... an children: randomised trial.
@nl
type
label
Effectiveness of quinine versu ...... an children: randomised trial.
@en
Effectiveness of quinine versu ...... an children: randomised trial.
@nl
prefLabel
Effectiveness of quinine versu ...... an children: randomised trial.
@en
Effectiveness of quinine versu ...... an children: randomised trial.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Effectiveness of quinine versu ...... an children: randomised trial.
@en
P2093
Ambrose O Talisuna
Daniel Kyabayinze
Fred Wabwire Mangen
James K Tibenderana
Jane Achan
P2860
P356
10.1136/BMJ.B2763
P407
P577
2009-07-21T00:00:00Z